Sort
130,381 grants matching “hiv”
Mid Southern Primary Care Networks Node
$999,998Li-Tzy T Wu · Duke University · UG1 · FY2019 · DA
IND-enabling preclinical development of a system for the multipurpose prevention of HIV and unintended pregnancy
$999,998Thomas J. Smith · Auritec Pharmaceuticals, Inc. · R44 · FY2020 · AI
New Class of Bright, Sharp, Tunable Near-Infrared Fluorophores for Flow Cytometry
$999,998Christopher J Macnevin · Nirvana Sciences, Inc. · R44 · FY2021 · AI
NYC Center of Excellence for Public Health Informatics
$999,998Farzad Mostashari · New York City Health/Mental Hygiene · P01 · FY2006 · CD
Therapy Against Recalcitrant C. albicans Infection
$999,998Thomas A Dahl · Arietis · R44 · FY2011 · AI
Optimizing Industrial-Scale GMP Processes for Recovering and Banking Deceased Donor Bone Marrow
$999,998Erik J Woods · Ossium Health, Inc. · R44 · FY2020 · AI
NYC Center of Excellence for Public Health Informatics
$999,998Farzad Mostashari · New York City Health/Mental Hygiene · P01 · FY2007 · CD
Preclinical development of a potent D-peptide RSV inhibitor
$999,998Brett D Welch · Navigen, Inc. · R44 · FY2018 · AI
TB Diagnostics at the Point of Care
$999,998Christopher Gerard Cooney · Akonni Biosystems, Inc. · R44 · FY2019 · AI
A single antiviral to treat multiple opportunistic infections
$999,998Stacy Remiszewski · Evrys Bio, Llc · R44 · FY2023 · AI
Preclinical development of a potent D-peptide RSV inhibitor
$999,998Brett D Welch · Navigen, Inc. · R44 · FY2017 · AI
IND-enabling preclinical development of a system for the multipurpose prevention of HIV and unintended pregnancy
$999,998Thomas J. Smith · Auritec Pharmaceuticals, Inc. · R44 · FY2019 · AI
A single antiviral to treat multiple opportunistic infections
$999,997Stacy Remiszewski · Evrys Bio, Llc · R44 · FY2019 · AI
Process development for manufacturing eCD4-Ig
$999,997Michael David Alpert · Emmune, Inc · R44 · FY2025 · AI
Optimizing SIV reservoir depletion by Tendel bsAb-98
$999,991Ellen Elizabeth Sparger · Tendel Therapies Inc. · R44 · FY2025 · AI
Novel spectinamide antibiotics for the treatment of MDR/XDR tuberculosis
$999,980Michelle M. Butler · Microbiotix, Inc · R44 · FY2014 · AI
IGF::OT::IGF HTS TO IDENTIFY INHIBITORS OF HIV-1 CAPSID DIMERIZATION
$999,976Roger Ptak · Southern Research Institute · N01 · FY2016 · AI
National Neurological AIDS Bank
$999,963Elyse J Singer · University Of California Los Angeles · U24 · FY2015 · MH
Health Promotion and Disease Prevention Research Center
$999,962Tabia Henry-Akintobi · Morehouse School Of Medicine · U48 · FY2014 · DP
Development of AAV vectors for long-term expression of eCD4-Ig
$999,959Michael David Alpert · Emmune, Inc · R44 · FY2018 · AI
Molecular Detection of Invasive Fungal Infections
$999,952Andrew E. Levin · Immunetics, Inc. · R44 · FY2016 · AI
STRENGTHENING THE RESPONSE TO THE HIV EPIDEMIC IN CENTRAL AMERICA AND PANAMA REGI
$999,949Erika Stolz · University Research Co, Llc · U2G · FY2010 · PS
Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO)
$999,893Pamina Mae Gorbach · University Of California Los Angeles · U24 · FY2017 · DA
CVD and Metabolic Complications of HIV/AIDS Data Coordinating Center
$999,885Elizabeth Renata Brown · University Of Washington · R01 · FY2008 · HL
Scaling Up Implementation Strategies to Improve the DIAGNOSE and PREVENT Pillars for Young MSM in Florida
$999,879Sylvie Naar-King · Florida State University · R01 · FY2025 · MH